Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04435808 · ClinicalTrials.gov registry record · Phase 1
Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19
A Phase 1 study, sponsored by University of New Mexico.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT04435808 is a Phase 1 study that was terminated before completion, run by University of New Mexico. The registered enrollment target is 1 participants.
The verdict
NCT04435808, a Phase 1 study, was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The HCW Prophylaxis (HCWP) Study, single, open and off label intervention study. Up to 350 participants will be assigned to group that takes HCQ or group that opts to not take study medication. Participants will be UNM HEALTH SYSTEM HCW at high risk for occupational exposure to SARSCoV- 2. Study timepoints will include Day 1 screening/enrollment, 30 day, 60 day, and 90 day assessments. Questionnaires will be collected in all timepoints.
Interventions
- DRUG Hydroxychloroquine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2020-04-14 |
| Est. Completion | 2020-07-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04435808
The ClinicalTrials.gov registry entry for NCT04435808 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hydroxychloroquine is the first listed.
NCT04435808 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04435808 about?
NCT04435808 is a clinical study titled "Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19". The HCW Prophylaxis (HCWP) Study, single, open and off label intervention study. Up to 350 participants will be assigned to group that takes HCQ or group that opts to not take study medication. Participants will be UNM HEALTH SYSTEM HCW at high risk for occupational exposure to SARSCoV- 2. Study tim...
What is the current status of trial NCT04435808?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2020-04-14. Estimated completion is 2020-07-15.
What interventions are being tested in trial NCT04435808?
The interventions under investigation include: Hydroxychloroquine (DRUG).
Who is sponsoring clinical trial NCT04435808?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.